Open house pharmaceutical discount agreements Bimatoprost, ATC S01EE03

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jun 03, 2028 · 644 days left·Open·Supplies·Framework

Inscrivez-vous pour sauvegarder Open documents

Structured notice only

Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Bimatoprost, ATC S01EE03

50/100

Score d'opportunité

PromisingLow complexity

SuppliesFrameworkOpen

Pourquoi ce score ?

Opportunité

50 / 100

Complexité

30 / 100

Facteurs de risque

No estimated value or minimum volume is provided; actual revenue may be low.

Requires submission in paper with two originals or electronic with qualified electronic signature; strict monthly deadl...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Aperçu

Strong opportunity

Faits clés

Framework procurement
Supplies contract
1 lot
Duration until Jul 2028
Supply of Bimatoprost (ATC S01EE03) pharmaceutical products
Non-exclusive discount agreements with AOK Bayern

Afficher le résumé complet

Open-house model for non-exclusive discount agreements for Bimatoprost (ATC S01EE03) with AOK Bayern. Any eligible pharmaceutical company can join at any time until 03.06.2028. No selection process; contracts are offered to all interested parties meeting eligibility criteria. Contract duration: 01.08.2026 to 31.07.2028. No estimated value provided.

Risques

No estimated value or minimum volume is provided; actual revenue may be low.

Requires submission in paper with two originals or electronic with qualified electronic signature; strict monthly deadl...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

Only pharmaceutical companies may apply

Certifications

Documents must be in German or accompanied by certified German translation

Administrative

Submission of signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed declaration of reliability

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria applicable (open-house model, no selection).

Acheteur

Nom

AOK Bayern - Die Gesundheitskasse

Localisation

München, DEU

[email protected]

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house pharmaceutical discount agreements Bimatoprost, ATC S01EE03

Non-exclusive discount agreements for Bimatoprost (ATC S01EE03) under the open-house model. Contracts can be concluded at any time until 03.06.2028, with earliest start 01.08.2026. All contracts end 31.07.2028. Terms are identical and non-negotiable.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Jul 2026 - Jul 2028

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria applicable (open-house model, no selection).

Date limite

Deadline Jun 03, 2028

Détails de la procédure

Date de publication: 14 Jun 2026
Langues: German

Métadonnées de référence

Base juridique: 32014L0024

Identifiants de référence

ID de l'appel d'offres: 406804-2026

Documents (2)

Document de consultation 1 Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3